The Latest Cardiac and Vascular News
ABBOTT PARK, Ill., July 6, 2020 /PRNewswire/ — Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the company’s next-generation Gallant™ implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices bring new benefits to patients with heart rhythm disorders, including […]
SYDNEY, July 6, 2020 /PRNewswire/ — CardieX Limited (ASX: CDX) (CardieX, the Company) announces that its wearables co-development partner, Blumio, Inc, has entered into a significant partnership with global semiconductor company Infineon Technologies AG (Infineon) for the development and commercialization of sensor technology based on Infineons’s radar chip and Blumio’s software and algorithms. CardieX has several […]
Company to Report Full Financial Results on August 6, 2020 VANCOUVER and MINNEAPOLIS, MN, July 06, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (NASDAQ, TSX: NVCN) today announced preliminary revenue results for the second quarter of 2020. Revenue for the quarter ended June 30, 2020 was approximately $295,000. Revenues were negatively impacted […]
Celixir provides update on ongoing clinical programme with lead therapeutic candidate CLXR-001 First patient successfully dosed in cardiomyopathy study Stratford-upon-Avon, UK: July, 6 2019 – Celixir, a privately-owned company discovering and developing life-saving advanced therapies, announces an update to its ongoing clinical programme with lead therapeutic candidate CLXR-001. The first patient was […]
Global “DISSECT-N” Post-Market Study to Broaden Evidence Base for Safety and Effectiveness of Commercially Available Endovascular Repair Technology DUBLIN, July 06, 2020 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the start of a prospective, observational, global, multi-center, real-world, post-market study to evaluate the safety and effectiveness of […]
BRISBANE, Calif., July 06, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) today announced the appointment of Denelle Waynick as General Counsel and Corporate Secretary. Ms. Waynick joins MyoKardia from UCB, Inc., bringing more than 25 years of domestic and international legal and business expertise in the healthcare and life-science […]
Commences voluntary Chapter 11 process with access to $30.8 million in DIP financing Files consensual plan of reorganization that would reduce approximately $180 million in debt and provide an approximately $30 million in additional exit financing Confirms launch of Alto this summer, steady production, continued clinical studies, and accelerated pipeline […]
The U.S. trial for CE-marked CBSO is designed to enroll up to 250 patients in a staged study approach BAAR, Switzerland, July 1, 2020 /PRNewswire/ — CARAG AG, a privately-held Swiss medical device development company, today announced receiving U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for its Carag Bioresorbable […]
PESSAC, France, July 2, 2020 /PRNewswire/ — inHEART, providing a cloud-based medical image analysis solution for cardiac interventions on patients with arrhythmias, has closed a round of EUR 3.7 million led by Elaia. These funds will be used to accelerate commercial development in Europe, access the US market, and advance its technology leadership with continued development of […]
THE WOODLANDS, Texas–(BUSINESS WIRE)–Berlin Heart Inc. announced they have completed the Post Approval Surveillance for the EXCOR® Pediatric Ventricular Assist Device, a requirement of the Post Market Approval (PMA) granted by the Food and Drug Administration (FDA), in June 2017. The final report submitted to the FDA confirmed the positive contemporary […]
